| 摘要 |
<p>Substances for the treatment of disorders associated with c-Jun, e.g. treatment of neurodegenerative diseases or treatment of cancer, have the ability to inhibit c-Jun N-terminal phosphorylation. Methods for screening such substances are provided.</p> |
